Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368693 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers
A Phase 3 study, sponsored by University of California, Davis.
- Terminated
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT00368693 is a Phase 3 study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 20 participants.
The verdict
NCT00368693, a Phase 3 study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy and side effects, if any, of Dermal - LSR combined with standard treatment. We hypothesize the treatment will provide beneficial results for diabetic patients suffering foot ulcers.
Interventions
- DEVICE Dermal - Living Skin Replacement (Dermal-LSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00368693
The ClinicalTrials.gov registry entry for NCT00368693 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dermal - Living Skin Replacement (Dermal-LSR) is the first listed.
NCT00368693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00368693 about?
NCT00368693 is a clinical study titled "Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers". The purpose of this study is to test the efficacy and side effects, if any, of Dermal - LSR combined with standard treatment. We hypothesize the treatment will provide beneficial results for diabetic patients suffering foot ulcers.
What is the current status of trial NCT00368693?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2005-08. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00368693?
The interventions under investigation include: Dermal - Living Skin Replacement (Dermal-LSR) (DEVICE).
Who is sponsoring clinical trial NCT00368693?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.